Inventor · disambiguated record
Lu Han
Also filed as: HAN LU
2 granted patents·15 pending applications·1 citations·filing 2012–2022
32Inventor score
Files withBIOHENG THERAPEUTICS LTD7NANJING BIOHENG BIOTECH CO LTD7CHILDRENS HOSPITAL MED CT1FOURTH MIL MED UNIV OF PEOPLES LIB ARMY1WANG ZENG-YU1
Top patents by PatentIndex Score
17 records- 0177US11896620B2Engineered immune cell and use thereofNANJING BIOHENG BIOTECH CO LTD·Filed 2021·Granted Feb 13, 2024·1 cites·22 claims
- 0253US2022275341A1Organoid mesoderm lineage diversificationCHILDRENS HOSPITAL MED CT·Filed 2020·Application pending·0 cites
- 0352US2023399398A1Cd7-targeting humanized antibody and use thereofBIOHENG THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 0452US2023390336A1Chimeric antigen receptor targeting cd7 and use thereofBIOHENG THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 0551US2024018236A1Cd19-targeting humanized antibody and use thereofBIOHENG THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 0651US2024052029A1Ror1-targeting antibody and use thereofBIOHENG THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 0750US2024082306A1Novel chimeric antigen receptor and use thereofBIOHENG THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 0850US2024043532A1Nkg2a-targeting antibody and use thereofBIOHENG THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 0948US2024009308A1Chimeric antigen receptor comprising novel co-stimulatory domain and use thereofNANJING BIOHENG BIOTECH CO LTD·Filed 2021·Application pending·0 cites
- 1048US2024009311A1Engineered immune cell and use thereofNANJING BIOHENG BIOTECH CO LTD·Filed 2021·Application pending·0 cites
- 1148US2024018251A1Bcma-targeting single-domain antibody and use thereofBIOHENG THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 1248US2023270858A1Novel co-stimulatory domain and use thereofNANJING BIOHENG BIOTECH CO LTD·Filed 2021·Application pending·0 cites
- 1347US2023242661A1Engineered immune cell expressing nk inhibitory molecule and use thereofNANJING BIOHENG BIOTECH CO LTD·Filed 2021·Application pending·0 cites
- 1446US2023248768A1Engineered immune cell for allotransplantationNANJING BIOHENG BIOTECH CO LTD·Filed 2021·Application pending·0 cites
- 1546US2023242877A1Immune cell comprising chimeric antigen receptor and use thereofNANJING BIOHENG BIOTECH CO LTD·Filed 2021·Application pending·0 cites
- 1644US11369602B2Use of tadalafil as protein arginine methyltransferase (PRMT5) inhibitorFOURTH MIL MED UNIV OF PEOPLES LIB ARMY·Filed 2020·Granted Jun 28, 2022·0 cites·7 claims
- 1730US2012278944A1Altered senescence for improved forage qualityWANG ZENG-YU·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lu Han files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →